• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:黄朝辉,胡海荣,雷贾毅,楚勇,叶德泳.新型苯并硫氮杂酮类非ATP竞争GSK-3β抑制剂的设计、合成和活性评价[J].中国现代应用药学,2012,29(11):988-992.
HUANG Zhaohui,HU Hairong,LEI Jiayi,CHU Yong,YE Deyong.Design, Synthesis and in Vitro Test of Novel Non-ATP Competitive Glycogen Synthase Kinase-3β(GSK-3β) Inhibitors[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(11):988-992.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2813次   下载 1950 本文二维码信息
码上扫一扫!
分享到: 微信 更多
新型苯并硫氮杂酮类非ATP竞争GSK-3β抑制剂的设计、合成和活性评价
黄朝辉1, 胡海荣2, 雷贾毅3, 楚勇3, 叶德泳3
1.浙江省宁波市药品检验所,浙江 宁波 315048;2.复旦大学生命科学学院,上海 200433;3.复旦大学药学院药化教研室,上海 200032
摘要:
目的 寻找新型的非ATP竞争糖原合成酶激酶-3β(GSK-3β)抑制剂。方法 针对GSK-3β的非ATP结合的底物作用位点为靶点,采用Autodock程序对类药性小分子库Maybridge进行虚拟筛选寻找新型GSK-3β抑制剂。采用克脑文格尔反应,环合及N-烷基化反应制备目标化合物。采用体外酶抑制活性测试目标化合物的活性。结果 化合物2-(2-呋喃基)-5-苄基-2,3-二氢苯并[b][1,4]硫氮杂-4(5H)-酮对GSK-3β具有中等抑制活性(IC50 47.69±2.38 μmol·L-1)。结论 活性化合物的结构与目前报道的其他GSK-3β抑制剂不同,可望作为新的先导化合物,值得进一步研究。
关键词:  糖原合成酶激酶-3β  虚拟筛选  抑制剂  合成
DOI:
分类号:
基金项目:
Design, Synthesis and in Vitro Test of Novel Non-ATP Competitive Glycogen Synthase Kinase-3β(GSK-3β) Inhibitors
HUANG Zhaohui1, HU Hairong2, LEI Jiayi3, CHU Yong3, YE Deyong3
1.Ningbo Institute for Drug Control, Ningbo 315048, China;2.School of Life Sciences, Fudan University, Shanghai 200433, China;3.School of Pharmacy, Fudan University, Shanghai 200032, China
Abstract:
OBJECTIVE To discover novel non-ATP competitive glycogen synthase kinase-3β(GSK-3β) inhibitors. METHODS A virtual screening was conducted by Autodock program, which docked the small drug-like molecules of Maybridge library at the non-ATP binding site of GSK-3β. The target compounds had been designed based on the virtual screening result and successfully synthesized through Knoevenagel reaction, cyclization and N-alkylation. The inhibition to GSK-3β was tested by in vitro enzamic test. RESULTS 5-benzyl-2-(furan-2-yl)-2,3-dihydrobenzo[b][1,4] thiazepin-4(5H)-one showed moderate inhibition to GSK-3β in vitro (IC50 47.69±2.38 μmol·L-1). CONCLUSION The discovered new active compound is structurally different to other inhibitors of GSK-3β and worthy of further study as a novel lead compound.
Key words:  glycogen synthase kinase-3β(GSK-3β)  virtual screening  inhibitor  synthesis
扫一扫关注本刊微信